Patents by Inventor James D Copp

James D Copp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chemical compounds
    Patent number: 7115621
    Abstract: Compounds of general structural formula (I) and use of the compounds and salts and solvates thereof, as therapeutic agents as inhibitors of phosphodiesterase 5 cardiovascular disorders
    Type: Grant
    Filed: April 2, 2002
    Date of Patent: October 3, 2006
    Assignee: Lilly Icos LLC
    Inventors: Jason S. Sawyer, Mark W. Orme, James D. Copp
  • Chemical compounds
    Publication number: 20040147542
    Abstract: Compounds of general structural formula (I) and use of the compounds and salts and solvates thereof, as therapeutic agents as inhibitors of phosphodiesterase 5 cardiovascular disorders.
    Type: Application
    Filed: February 9, 2004
    Publication date: July 29, 2004
    Inventors: Jason S. Sawyer, Mark W. Orme, James D. Copp
  • Process for preparing benzyl-substituted rhodanine derivatives
    Patent number: 6201127
    Abstract: The instant invention provides a novel process for preparing benzyl-substituted rhodanine derivatives. Also provided are novel benzyl-substituted thiolamides and benzyl-substituted hemithioacetals. Such compounds are useful as intermediates in preparing the compounds by the process of the instant invention.
    Type: Grant
    Filed: June 10, 1999
    Date of Patent: March 13, 2001
    Assignee: Eli Lilly and Company
    Inventors: James D Copp, Francis O Ginah, Marvin M. Hansen, Douglas P Kjell, Brian J Slattery
  • Process for preparing benzyl-substituted rhodanine derivatives
    Patent number: 6005142
    Abstract: The instant invention provides a novel process for preparing benzyl-substituted rhodanine derivatives. Also provided are novel benzyl-substituted thiolamides and benzyl-substituted hemithioacetals. Such compounds are useful as intermediates in preparing the compounds by the process of the instant invention.
    Type: Grant
    Filed: February 25, 1998
    Date of Patent: December 21, 1999
    Assignee: Eli Lilly and Company
    Inventors: James D Copp, Francis O Ginah, Marvin M. Hansen
  • Bis-piperidinyl non-peptidyl neurokinin receptor antagonists
    Patent number: 5530009
    Abstract: This invention provides novel compound of the formula ##STR1## which is neurokinin receptor antagonist.
    Type: Grant
    Filed: June 5, 1996
    Date of Patent: June 25, 1996
    Assignee: Eli Lilly and Company
    Inventors: Sung Yong S. Cho, James D. Copp, Francis O. Ginah, Guy J. Hansen, Philip A. Hipskind, Bret E. Huff, Michael J. Martinelli, Michael A. Staszak, Roger W. Tharp-Taylor
  • Process for 3-exomethylenecepham sulfoxide esters
    Patent number: 4950753
    Abstract: 3-Exomethylenecepham sulfoxide esters are obtained in improved yields via cyclization of 3-methyl-2-(4-chlorosulfinyl-2-oxo-3-acylamino-1-azetidinyl)-3-butenoic acid esters under anhydrous conditions with stannic chloride in the presence of both an oxo compound, e.g., an ether such as diethyl ether, a ketone such as acetone or methylethyl ketone, and an unsaturated compound, e.g., an alkene such as 1- or 2-hexene, a non-conjugated alkadiene such as 1,4-hexadiene, a cycloalkene such as cyclohexene, an allene, or a non-conjugated cycloalkadiene such as 1,4-cyclohexadiene.
    Type: Grant
    Filed: May 17, 1989
    Date of Patent: August 21, 1990
    Assignee: Eli Lilly and Company
    Inventors: James D. Copp, Gregg A. Tharp